
Trian Slashes Invesco Stake 83%, Buys Rentokil
Nelson Peltz's Trian Fund Management cut its Invesco stake to 280,000 shares in the third quarter, down from 1.63 million shares three months earlier — an 83% reduction disclosed in Trian's newest 13F filing with the SEC. At the same time, Trian opened a fresh position of roughly 597,000 shares in Rentokil Initial, worth close to $11.8 million. Trian has pushed Invesco toward a sale or merger for years; this is its sharpest retreat from that bet yet. $IVZ